drugset / Trial / NCT07616973

Letrozole vs. Clomiphene Citrate Plus Tamoxifen for Ovulation Induction and Pregnancy Outcomes.

NCT07616973

Phase 3 Active not recruiting 240 enrolled Sana'a University Al-Thawra Modern General Hospital · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

Infertility is a common reproductive health problem. Ovulation induction is a key treatment for women with anovulatory infertility. Letrozole and clomiphene citrate are widely used medications for ovulation induction. Tamoxifen has also been used as an alternative or adjunct therapy. This randomized clinical trial aims to compare the effectiveness of letrozole versus clomiphene citrate combined with tamoxifen for ovulation induction and pregnancy outcomes in infertile women. The outcomes include ovulation rate, pregnancy rate, endometrial thickness, follicular development, Miscarriage rate, and Live birth rate. The study will be conducted at Al-Thawra Hospital in Sana'a, Yemen, under the supervision of Sana'a University. Keywords: Infertility, Ovulation Induction, Letrozole, Clomiphene Citrate, Tamoxifen

Timeline

Start
2023-05-01
Primary completion
2026-05-30
Completion
2026-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Clomiphene Other / unclassified
Subject Letrozole Other / unclassified
Subject Tamoxifen Small molecule

Indications